Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Shockwave Medical’s IVL catheter for peripheral lesions linked to positive 1-year data
The new findings, presented during a late-breaking presentation, focused on 110 PAD patients treated with Shockwave Medical's Javelin Peripheral IVL Catheter.
Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device
Tulyp Medical, a French medtech startup, has emerged from stealth focused on securing FDA clearance for a patented perfusion device.
Pulmonary embolism thrombectomy use increases by more than 700%
Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT).
Cardiologist Peter Soukas becomes chief medical officer of carotid stent company
The company said the move will help it prepare for what is expected to be a rapid expansion of carotid stenting.
How to minimize bleeding risks after TAVR
Bleeding events remain a serious complication after TAVR. By identifying high-risk patients early and planning ahead, however, care teams can keep them to a minimum.

transcatheter aortic valve replacement (TAVR) procedure guided by CT fusion imaging on a patient with heart failure and a blood clot

Cardiologists and surgeons perform first TAVR using CT imaging guidance on HF patient with blood clot

“We believe this case is potentially groundbreaking," one interventional cardiologist said.

The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.

VIDEO: Shockwave Medical demonstrates faster intravascular lithotripsy at ACC.22

The new Shockwave Medical M5+ peripheral intravascular lithotripsy (IVL) catheter made its debut at ACC.22.

Carotid endarterectomy (CEA) is not associated with a significant reduction in the risk of dementia, according to a new analysis published in the European Journal of Vascular & Endovascular Surgery.[1] However, the study’s authors noted, it did still lead to considerable improvements in stroke risk.

Carotid endarterectomy does not reduce long-term dementia risk

However, researchers noted, there was still a clear improvement in stroke risk.

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance.

How to improve shared decision-making among vascular surgeons and their patients

Researchers introduced decision support tools to 13 different hospitals, tracking the overall impact on shared-decision making and patient knowledge.

Societies share new recommendations for endovascular specialists treating chronic limb-threatening ischemia

Given high mortality and a high threat of limb loss for CLTI patients, the statement aims to standardize core competencies and improve patient outcomes.

USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older

These recommendations, the group emphasized, do not include patients with a history of CVD or those who are already taking aspirin for another reason.

4 support catheters receive FDA clearance for coronary use

The catheters were developed to be used during percutaneous coronary intervention procedures for coronary artery disease.

Vascular & Endovascular

Shockwave Medical’s IVL catheter for peripheral lesions linked to positive 1-year data

Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device

Pulmonary embolism thrombectomy use increases by more than 700%

Cardiologist Peter Soukas becomes chief medical officer of carotid stent company

How to minimize bleeding risks after TAVR